Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome - PubMed (original) (raw)
Clinical Trial
. 2002 Sep;25(9):1516-21.
doi: 10.2337/diacare.25.9.1516.
Affiliations
- PMID: 12196420
- DOI: 10.2337/diacare.25.9.1516
Clinical Trial
Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome
Ulf Risérus et al. Diabetes Care. 2002 Sep.
Abstract
Objective: Conjugated linoleic acid (CLA) is a group of dietary fatty acids with antiobesity and antidiabetic effects in some animals. The trans10cis12 (t10c12) CLA isomer seems to cause these effects, including improved insulin sensitivity. Whether such isomer-specific effects occur in humans is unknown. The aim of this study was to investigate whether t10c12 CLA or a commercial CLA mixture could improve insulin sensitivity, lipid metabolism, or body composition in obese men with signs of the metabolic syndrome.
Research design and methods: In a randomized, double-blind controlled trial, abdominally obese men (n = 60) were treated with 3.4 g/day CLA (isomer mixture), purified t10c12 CLA, or placebo. Euglycemic-hyperinsulinemic clamp, serum hormones, lipids, and anthropometry were assessed before and after 12 weeks of treatment.
Results: Baseline metabolic status was similar between groups. Unexpectedly, t10c12 CLA increased insulin resistance (19%; P < 0.01) and glycemia (4%; P < 0.001) and reduced HDL cholesterol (-4%; P < 0.01) compared with placebo, whereas body fat, sagittal abdominal diameter, and weight decreased versus baseline, but the difference was not significantly different from placebo. The CLA mixture did not change glucose metabolism, body composition, or weight compared with placebo but lowered HDL cholesterol (-2%; P < 0.05).
Conclusions: These results reveal important isomer-specific metabolic actions of CLA in abdominally obese humans. A CLA-induced insulin resistance has previously been described only in lipodystrophic mice. Considering the use of CLA-supplements among obese individuals, it is important to clarify the clinical consequences of these results, but they also provide physiological insights into the role of specific dietary fatty acids as modulators of insulin resistance in humans.
Similar articles
- Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance.
Risérus U, Basu S, Jovinge S, Fredrikson GN, Arnlöv J, Vessby B. Risérus U, et al. Circulation. 2002 Oct 8;106(15):1925-9. doi: 10.1161/01.cir.0000033589.15413.48. Circulation. 2002. PMID: 12370214 Clinical Trial. - Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men.
Risérus U, Vessby B, Arnlöv J, Basu S. Risérus U, et al. Am J Clin Nutr. 2004 Aug;80(2):279-83. doi: 10.1093/ajcn/80.2.279. Am J Clin Nutr. 2004. PMID: 15277146 Clinical Trial. - Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial.
Risérus U, Berglund L, Vessby B. Risérus U, et al. Int J Obes Relat Metab Disord. 2001 Aug;25(8):1129-35. doi: 10.1038/sj.ijo.0801659. Int J Obes Relat Metab Disord. 2001. PMID: 11477497 Clinical Trial. - Conjugated linoleic acid and obesity control: efficacy and mechanisms.
Wang YW, Jones PJ. Wang YW, et al. Int J Obes Relat Metab Disord. 2004 Aug;28(8):941-55. doi: 10.1038/sj.ijo.0802641. Int J Obes Relat Metab Disord. 2004. PMID: 15254484 Review.
Cited by
- The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium.
Ip MM, McGee SO, Masso-Welch PA, Ip C, Meng X, Ou L, Shoemaker SF. Ip MM, et al. Carcinogenesis. 2007 Jun;28(6):1269-76. doi: 10.1093/carcin/bgm018. Epub 2007 Jan 27. Carcinogenesis. 2007. PMID: 17259656 Free PMC article. - Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism: a double blind, randomized, controlled cross-over study.
Herrmann J, Rubin D, Häsler R, Helwig U, Pfeuffer M, Auinger A, Laue C, Winkler P, Schreiber S, Bell D, Schrezenmeir J. Herrmann J, et al. Lipids Health Dis. 2009 Aug 18;8:35. doi: 10.1186/1476-511X-8-35. Lipids Health Dis. 2009. PMID: 19689798 Free PMC article. Clinical Trial. - Dietary protein modulates the effect of CLA on lipid metabolism in rats.
Akahoshi A, Koba K, Ichinose F, Kaneko M, Shimoda A, Nonaka K, Yamasaki M, Iwata T, Yamauchi Y, Tsutsumi K, Sugano M. Akahoshi A, et al. Lipids. 2004 Jan;39(1):25-30. doi: 10.1007/s11745-004-1197-3. Lipids. 2004. PMID: 15055231 - Plasma Industrial and Ruminant Trans Fatty Acids and Incident Type 2 Diabetes in the EPIC-Potsdam Cohort.
Prada M, Wittenbecher C, Eichelmann F, Wernitz A, Kuxhaus O, Kröger J, Weikert C, Schulze MB. Prada M, et al. Diabetes Care. 2022 Apr 1;45(4):845-853. doi: 10.2337/dc21-1897. Diabetes Care. 2022. PMID: 35129607 Free PMC article. - The diversity of health effects of individual trans fatty acid isomers.
Gebauer SK, Psota TL, Kris-Etherton PM. Gebauer SK, et al. Lipids. 2007 Sep;42(9):787-99. doi: 10.1007/s11745-007-3095-8. Epub 2007 Aug 11. Lipids. 2007. PMID: 17694343 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical